A 52-Week Randomized, Double-Blind, Multicenter, Mechanistic Study With a 24-Week Open-Label Follow-Up to Evaluate the Effect of Avandia on Bone in Postmenopausal Women With Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 24 May 2017
At a glance
- Drugs Rosiglitazone (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 16 Oct 2012 Results assessing the effects of treatment on osteoclast activity presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research.
- 24 Mar 2012 Substudy assessing muscle mass and adiposity presented at the 2012 IOF World Congress on Osteoporosis and 11th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History